Andon Bio
Aurora, US · Founded 2026 · Delaware corporation
Andon Bio is a spinout from the University of Colorado School of Medicine developing aa-tRNA-seq, a molecular biology method for studying protein translation and tRNA aminoacylation. The company builds experimental and computational tools for research into cellular translation mechanisms.
Founders & leadership
Andon Bio was founded in 2026 by Laura White, PhD, J. Lorsch, and Jack Szostak.
LW
Laura White, PhDCo-founder
JL
J. LorschCo-founder, Professor at University of Colorado School of Medicine
JS
Jack SzostakCo-founder
LW
Laura WhiteinExecutive
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2026
▶$250KraisedJun 2026 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedJun 2026 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
- Laura WhiteExecutive Officer
- Offering amount
- $2M
- Amount sold
- $250K
- Minimum investment
- $50K
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Andon Bio do?
- Andon Bio is a spinout from the University of Colorado School of Medicine developing aa-tRNA-seq, a molecular biology method for studying protein translation and tRNA aminoacylation. The company builds experimental and computational tools for research into cellular translation mechanisms.
- Who founded Andon Bio?
- Andon Bio was founded by Laura White, PhD, J. Lorsch, Jack Szostak in 2026.
- How much funding has Andon Bio raised?
- Andon Bio has disclosed $250K raised across 1 round.
- Where is Andon Bio headquartered?
- Andon Bio is headquartered in Aurora, US.